secwatch.observer — SEC 8-K summary
======================================

Issuer:     Healthcare Triangle, Inc. (HCTI)
CIK:        0001839285
Form:       8-K/A
Filed at:   2025-09-02T23:59:59+00:00
Accession:  0001213900-25-082708
Event type: m_and_a
Sentiment:  neutral
Materiality: 0.45
Item codes: 9.01, 1.01
LLM model:  deepseek-v4-flash:cloud@v2

HCTI amends acquisition terms to give seller 1.388M shares after reverse split; discloses audited financials
--------------------------------------------------------------------------------

- Amendment replaces stock consideration with 1,388,041 restricted shares, reflecting 1-for-249 reverse split, subject to shareholder approval.
- Niyama audited FY2024: revenue $3K, net loss $37K; Ezovion: revenue $258K, net income $13K.
- Pro forma combined FY2024 revenue $11.96M, net loss $5.99M; HCTI standalone had $1.1M AR and $2.65M short-term borrowing.
- HCTI standalone total liabilities $9.78M vs total assets $7.66M; combined assets $8.24M.
- Acquired entities contribute minimal revenue/assets relative to HCTI's existing losses; deal still requires shareholder approval.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1839285/000121390025082708/0001213900-25-082708-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1839285/000121390025082708/ea0255323-8ka1_health.htm
  HTML page:      https://secwatch.observer/filing/0001213900-25-082708

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer